1. 1. Hyams ES, Munver R, Bird VG, Uberoi J, Shah O. Flexible ureterorenoscopy and holmium laser lithotripsy for the management of renal stone burdens that measure 2 to 3 cm: a multi-institutional experience. Journal of endourology. 2010;24(10):1583-8.
2. Robertson W, Peacock M, Nordin B. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clinical science. 1971;40(5):365-74.
3. Robertson W, Peacock M, Nordin B. Calcium crystalluria in recurrent renal-stone formers. The Lancet. 1969;294(7610):21-4.
4. Tsujihata M. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. International Journal of Urology. 2008;15(2):115-20.
5. Khan S. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urological research. 1995;23(2):71-9.
6. Selvam R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urological research. 2002;30(1):35-47.
7. Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Experimental Nephrology. 2004;98(2):e55-e60.
8. Hovda KE, Guo C, Austin R, McMartin KE. Renal toxicity of ethylene glycol results from internalization of calcium oxalate crystals by proximal tubule cells. Toxicology letters. 2010;192(3):365-72.
9. Moriyama MT, Suga K, Miyazawa K, Tanaka T, Higashioka M, Noda K, et al. Inhibitions of urinary oxidative stress and renal calcium level by an extract of Quercus salicina Blume/Quercus stenophylla Makino in a rat calcium oxalate urolithiasis model. International journal of Urology. 2009;16(4):397-401.
10. Khan SR. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urological research. 2005;33(5):349-57.
11. Khand F, Gordge MP, Robertson W, Noronha-Dutra A, Hothersall J. Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells. Free Radical Biology and Medicine. 2002;32(12):1339-50.
12. Hirose M, Yasui T, Okada A, Hamamoto S, Shimizu H, Itoh Y, et al. Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. International journal of urology. 2010;17(1):83-92.
13. Thamilselvan S, Khan SR, Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urological research. 2003;31(1):3-9.
14. Marangella M, Bruno M, Cosseddu D, Manganaro M, Tricerri A, Vitale C, et al. Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron. 1990;54(4):302-6.
15. Kristensen C, Parks JH, Lindheimer M, Coe FL. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney international. 1987;32(5):749-53.
16. Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial–. The American journal of clinical nutrition. 2009;91(3):565-70.
17. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, et al. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney international. 2002;61(3):975-87.
18. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. The Journal of urology. 1997;158(6):2069-73.
|